← Eichor
Study identifier: NCT05868928 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Condition: Brain Metastases · Radiosurgery  ·  Sponsor: Asan Medical Center

PhaseN/A
Planned participants132
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This trial uses multi-parametric magnetic resonance imaging (MRI) to develop and validate imaging risk score to predict radiation necrosis in participants with brain metastasis treated with radiation therapy. Diagnostic procedures, such as multi-parametric magnetic resonance imaging (MRI), may improve the ability to diagnose radiation necrosis early and help establish treatment strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Ho Sung Kim, MD, PhD  ·  +82230105682  ·  radhskim@gmail.com

Ji Eun Park, MD, PhD  ·  +82230101505  ·  jieunp@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Asan Medical CenterSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05868928